| RPRX |
Royalty Pharma plc |
90%
|
Reciprocal relationship from RPRX graph: Reciprocal relationship from PRTC graph: Reciprocal relationship from RPRX graph: Reciprocal relationship from PRTC graph: Reciprocal relationship from RPRX g… |
| RPRX |
Royalty Pharma plc |
90%
|
Upon closing, we received an upfront payment of $100.0 million from Royalty Pharma |
| SPTX |
SPTX |
72%
|
Reciprocal relationship from SPTX graph: Reciprocal relationship from PRTC graph: Reciprocal relationship from SPTX graph: Reciprocal relationship from PRTC graph: . During the year ended December 31… |
| SPTX |
SPTX |
72%
|
. During the year ended December 31, 2024 , Seaport Therapeutics, Inc. was deconsolidated and as such, $ 225 in net intangible assets were derecognized. The Group tested all intangible assets for imp… |
| VOR |
Vor Biopharma Inc. |
72%
|
er the Group participates in the policy making processes of the investee, whether there is any interchange of managerial personnel, whether there is any essential technical information provided to th… |
| VOR |
Vor Biopharma Inc. |
72%
|
Reciprocal relationship from VOR graph: Reciprocal relationship from PRTC graph: Reciprocal relationship from VOR graph: Reciprocal relationship from PRTC graph: er the Group participates in the poli… |
| SEAPORT-THERAPEUTICS |
SEAPORT-THERAPEUTICS |
70%
|
we entered into an Asset Transfer Agreement, by and among Seaport, PureTech Health LLC and PureTech LYT, Inc. |
| ARIYA-THERAPEUTICS-INC |
ARIYA-THERAPEUTICS-INC |
62%
|
er the Group participates in the policy making processes of the investee, whether there is any interchange of managerial personnel, whether there is any essential technical information provided to th… |
| CAPSTAR-SPECIAL-PURPOSE-ACQUISITION-CORP |
CAPSTAR-SPECIAL-PURPOSE-ACQUISITION-CORP |
62%
|
As Gelesis ceased operations in October 2023, the fair value of the Gelesis 2023 Warrants was written down to $ 0 as of December 31, 2023 . During the year ended December 31, 2023 , the Group recogni… |
| COBENFY-THE-GROUP |
COBENFY-THE-GROUP |
62%
|
nt. A significant increase or decrease in estimated royalty payments, or a significant shift in the timing of cash flows, will materially impact the sale of future royalties liability, interest expen… |
| CONTINGENCIES-THE-GROUP |
CONTINGENCIES-THE-GROUP |
62%
|
Group’s subsidiaries have issued preferred shares that include the right to receive a payment in the event of any voluntary or involuntary liquidation, dissolution or winding up of a subsidiary, incl… |
| DECONSOLIDATED-FOUNDED-ENTITY-INVESTMENTS-THE-GR |
DECONSOLIDATED-FOUNDED-ENTITY-INVESTMENTS-THE-GR |
62%
|
Group’s subsidiaries have issued preferred shares that include the right to receive a payment in the event of any voluntary or involuntary liquidation, dissolution or winding up of a subsidiary, incl… |
| DIRECTORS-THE-GROUP |
DIRECTORS-THE-GROUP |
62%
|
. As of December 31, 2025 and December 31, 2024 , the Group’s investment in Vedanta convertible preferred shares was held at fair value of $ 553 and $ 11,163 , respectively, and categorized as Level … |
| FINANCIAL-ASSETS-THE-GROUP |
FINANCIAL-ASSETS-THE-GROUP |
62%
|
the case. The Group evaluates if it maintains significant influence over associates by assessing if the Group has the power to participate in the financial and operating policy decisions of the assoc… |
| FINANCIAL-INSTRUMENTS-CLASSIFICATION-THE-GROUP |
FINANCIAL-INSTRUMENTS-CLASSIFICATION-THE-GROUP |
62%
|
the case. The Group evaluates if it maintains significant influence over associates by assessing if the Group has the power to participate in the financial and operating policy decisions of the assoc… |
| FINANCIAL-INSTRUMENTS-THE-GROUP |
FINANCIAL-INSTRUMENTS-THE-GROUP |
62%
|
nt. A significant increase or decrease in estimated royalty payments, or a significant shift in the timing of cash flows, will materially impact the sale of future royalties liability, interest expen… |
| FINANCIAL-LIABILITIES-THE-GROUP |
FINANCIAL-LIABILITIES-THE-GROUP |
62%
|
pected lifetime losses. Such losses are determined taking into account previous experience, credit rating and economic stability of counterparty and economic conditions. When a trade receivable is de… |
| FOREIGN-EXCHANGE-RISK-THE-GROUP |
FOREIGN-EXCHANGE-RISK-THE-GROUP |
62%
|
Group’s subsidiaries have issued preferred shares that include the right to receive a payment in the event of any voluntary or involuntary liquidation, dissolution or winding up of a subsidiary, incl… |
| FUTURE-ROYALTIES-LIABILITY-THE-GROUP |
FUTURE-ROYALTIES-LIABILITY-THE-GROUP |
62%
|
the case. The Group evaluates if it maintains significant influence over associates by assessing if the Group has the power to participate in the financial and operating policy decisions of the assoc… |
| GALLOP-ONCOLOGY-INC |
GALLOP-ONCOLOGY-INC |
62%
|
er the Group participates in the policy making processes of the investee, whether there is any interchange of managerial personnel, whether there is any essential technical information provided to th… |
| GELESIS-HOLDINGS-INC |
GELESIS-HOLDINGS-INC |
62%
|
As Gelesis ceased operations in October 2023, the fair value of the Gelesis 2023 Warrants was written down to $ 0 as of December 31, 2023 . During the year ended December 31, 2023 , the Group recogni… |
| IMPAIRMENT-THE-GROUP |
IMPAIRMENT-THE-GROUP |
62%
|
the case. The Group evaluates if it maintains significant influence over associates by assessing if the Group has the power to participate in the financial and operating policy decisions of the assoc… |
| JEF |
Jefferies Financial Group Inc. |
62%
|
Reciprocal relationship from JEF graph: Reciprocal relationship from PRTC graph: Reciprocal relationship from JEF graph: Reciprocal relationship from PRTC graph: Reciprocal relationship from JEF grap… |
| JEFFERIES-INTERNATIONAL-LIMITED |
JEFFERIES-INTERNATIONAL-LIMITED |
62%
|
. During the year ended December 31, 2024 , Seaport Therapeutics, Inc. was deconsolidated and as such, $ 225 in net intangible assets were derecognized. The Group tested all intangible assets for imp… |
| LEASES-THE-GROUP |
LEASES-THE-GROUP |
62%
|
net investment in the associate to its recoverable amount and recording any excess as an impairment loss. Employee Benefits Short-Term Employee Benefits Short-term employee benefit obligations are me… |
| N-A-N-A-ENTREGA-INC |
N-A-N-A-ENTREGA-INC |
62%
|
er the Group participates in the policy making processes of the investee, whether there is any interchange of managerial personnel, whether there is any essential technical information provided to th… |
| NON-FINANCIAL-ASSETS-THE-GROUP |
NON-FINANCIAL-ASSETS-THE-GROUP |
62%
|
e Capital Ordinary shares are classified as equity. The Group's equity is comprised of share capital, share premium, merger reserve, other reserve, translation reserve, and retained earnings/accumula… |
| PURETECH-LLC |
PURETECH-LLC |
62%
|
. During the year ended December 31, 2024 , Seaport Therapeutics, Inc. was deconsolidated and as such, $ 225 in net intangible assets were derecognized. The Group tested all intangible assets for imp… |
| PURETECH-LYT-INC |
PURETECH-LYT-INC |
62%
|
er the Group participates in the policy making processes of the investee, whether there is any interchange of managerial personnel, whether there is any essential technical information provided to th… |
| PURETECH-MANAGEMENT-INC |
PURETECH-MANAGEMENT-INC |
62%
|
er the Group participates in the policy making processes of the investee, whether there is any interchange of managerial personnel, whether there is any essential technical information provided to th… |
